Recent Physicians' Offices Research for November 2020

Topics: Diabetes, Physicians' Offices
Regions: United States
Physician Views: Ofev Approved, Esbriet Label Updated – What Impact On IPF-Treating Pulmonologists In The EU5?
Topics: Physicians' Offices, Manufacturing, Packaging & Detailing, Respiratory/Pulmonary
Trends in Preventative Healthcare (Technical Insights)
Topics: Obesity, Physicians' Offices, Services, Cardiovascular
Health care System Development in Kenya and Rwanda
Topics: Hospitals & Clinics, Physicians' Offices, Services
Regions: Kenya, Rwanda
Physician Views: Do cardiologists agree with payer rhetoric on PCSK9 inhibitors?
Topics: Physicians' Offices, Cardiovascular
Physician Views: Will PEGASUS data make AstraZeneca's Brilinta fly?
Topics: Physicians' Offices, Pharmaceuticals Company Reports, Clinical Trial
Physician Views: CMS guidance on biosimilar reimbursement – what do oncologists and rheumatologists think?
Topics: Biosimilars, Physicians' Offices
Physician Views: What commercial impact for Eylea from the Protocol T study in diabetic macular oedema?
Topics: Diabetes, Physicians' Offices, Ophthalmology
Physician Views: With Januvia data looming, what impact will FDA AdComm have on use of DPP-IV inhibitors?
Topics: Physicians' Offices, Clinical Trial
Physician Views: Assessing recent commercial dynamics in the multiple sclerosis market
Topics: Multiple Sclerosis (MS), Physicians' Offices
Physician Views: Evaluating the launch of Novartis' Cosentyx for psoriasis
Topics: Biotechnology Company Reports, Psoriasis, Physicians' Offices, Manufacturing, Packaging & Detailing
Building Strong Cross-Functional Medical Affairs Teams
Topics: Physicians' Offices, Healthcare Administration
Medical Affairs Reputations (US): Multiple Sclerosis
Topics: Multiple Sclerosis (MS), Physicians' Offices
Regions: United States
Physical Therapists Global Market Briefing 2017
Topics: Physicians' Offices
Regions: Global
Patient Portals in Africa
Topics: Physicians' Offices, Internet & e-Health, Portals/Vertical Sites
Physician Views: Are Dermatologists Ready For A New Class Of Psoriasis Therapies?
Topics: Psoriasis, Physicians' Offices, Dermatology
Physician Views: The Hepatitis C Pricing War - What Impact On Prescribers?
Topics: Hepatitis, Physicians' Offices, Regulation & Policy, Pricing
Physician Views – Sanofi secures US Toujeo approval, but are endocrinologists convinced?
Topics: Physicians' Offices, Pharmaceuticals Company Reports, Clinical Trial
Regions: United States
Physician Views: Which companies excel in diabetes drug marketing and why?
Topics: Diabetes, Physicians' Offices
Physician Views: Assessing competition in the idiopathic pulmonary fibrosis market
Topics: Physicians' Offices, Drug Discovery, Respiratory/Pulmonary
Physician Views: How have recent data, study design events shaped doctors’ thinking on lead NASH agents
Topics: Physicians' Offices, Prescription Drugs, Drug Discovery
Physician Views: Will patient switching studies support biosimilar adoption?
Topics: Biosimilars, Physicians' Offices
Physician Views: How do doctors see Praluent and Repatha stacking up after FDA panel meetings?
Topics: Physicians' Offices, Regulation & Policy, Prescription Drugs

Prev  | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8  | 9  | 10  | Next


About is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.